Searchable abstracts of presentations at key conferences in endocrinology

ea0020p361 | Diabetes and Cardiovascular | ECE2009

Carotid intima media thickness and serum osteoprotegerin and RANKL levels in diabetic and prediabetic patients

Isildak Serife Mehlika , Barak Anil , Yesilkaya Yakup , Akata Deniz , Gurlek Omer Alper

While well defined for their roles in new bone formation, osteoprotegerin and RANK-ligand (RANKL) are also being questioned for their possible association with the atherosclerotic process since the similarity between the pathogenic process of atherosclerotic plaque calcification and new bone formation is recently under observation. In our study we aimed to find whether there is an association between OPG and RANKL levels and carotid intima media thickness (taken as a measure o...

ea0056p547 | Obesity | ECE2018

Assessment of macrophage apoptosis inhibitor (AIM), monocyte chemotactic protein-1 (MCP-1) and C reactive protein (CRP) levels in patients with metabolic syndrome

Savas Emine Merve , Samadi Afshin , Baykal Hanife Seda , Unluturk Ugur , Lay Incilay , Isikhan Selen Yilmaz , Gurlek Omer Alper

Metabolic syndrome is an important health problem that has been shown to be associated with cardiovascular disease and mortality. Recent studies have shown the importance of inflammation in visceral fat tissue. Macrophage apoptosis inhibitor (AIM) and monocyte chemotactic protein (MCP-1) are molecules that cause migrating to visceral fat tissue of M1 macrophages that initiate adipocyte inflammation. The aim of this study is to understand the role of these molecules in the path...